Extension to Bridging Loan

30th Apr 2025 10:45

RNS Number : 8310G
Argentex Group PLC
30 April 2025
 

30 April 2025

 

Argentex Group plc

("Argentex" or the "Company")

 

Extension to Bridging Loan

 

Further to the 25 April 2025 announcement regarding the Recommended Acquisition of Argentex by IFX Payments, the Company announces that in response to a request yesterday for £3 million and €1.2 million incremental Initial Amount (IA) from the Company's principal Tier 1 Liquidity Provider, the Company has today reached agreement regarding the provision of additional liquidity support from IFX Payments. These IA amounts will be held by the Tier 1 Liquidity Provider and represent ring-fenced capital.

 

This funding will be provided by way of an immediate £4 million extension to the Bridging Loan Facility, as announced on 24 April 2025, and will be provided on the same terms as those previously disclosed. The Company also confirms it is in discussions with IFX Payments regarding the provision of a larger, revolving credit facility (RCF) to assist with the management of the Company's continuing liquidity and working capital needs.

 

As announced last week, it was essential that Argentex took urgent steps to secure significant further immediate ongoing liquidity support and consequently, trading in the Company's Ordinary Shares was suspended.

 

In light of the requirement for the Company to secure significant further immediate ongoing liquidity support by way of the revolving credit facility in the coming days, trading in the Company's Ordinary Shares will remain suspended.

 

Further announcements will be made in due course.

 

For further information, please contact:

 

Argentex Group PLC

Tim Rudman - Interim Chief Executive Officer

Guy Rudolph - Chief Financial Officer

[email protected]

 

Teneo (Financial PR to Argentex)

James Macey-White / Victoria Boxall / Riann Cato

[email protected], 020 7260 2700

 

Singer Capital Markets (Financial Adviser, Nominated Adviser and Broker to Argentex)

Tom Salvesen / James Maxwell / James Todd

020 7496 3000

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FURFIFVASFIIVIE